Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Search
Drug Profile

Research programme: small molecule therapeutics - e-therapeutics

Alternative Names: ETS 2123; ETS 5200; ETS 6114; ETS 7211; ETS-6200; ETS2300; ETS2400; ETX 6201; ETX 6765; ETXP-009171; ETXP-009181; ETXP-009425

Latest Information Update: 28 Apr 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator e-Therapeutics
  • Class Small molecules
  • Mechanism of Action Hedgehog cell signalling pathway inhibitors; Protein modulators; Telomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer; Fibrosis; Neurodegenerative disorders; Viral infections
  • Discontinued Age-related macular degeneration; Pain

Most Recent Events

  • 28 Apr 2022 No recent reports of development identified for research development in Fibrosis in United Kingdom
  • 28 Aug 2021 No recent reports of development identified for preclinical development in Neurodegenerative-disorders in United Kingdom
  • 28 Aug 2021 No recent reports of development identified for preclinical development in Viral-infections in United Kingdom

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days

Latest webinar now available!

Our latest webinar, Navigating the Complex Landscape of Clinical Trials: Trends, Global Impact, including Hits & Misses 2024, is available now. Key topics include an analysis of trials with both positive and negative outcomes, failed trials of 2024, and impactful trials of 2024 that contributed to regulatory approvals or company revenue, followed by an outlook on a few pivotal trials to watch in 2025.

Watch here!